Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Nerve”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT00826930
What this trial is testing

Trans Sodium Crocetinate (TSC) Study of Intra-tumoral Oxygen Concentration, Safety, and Pharmacokinetics in Patients With High Grade Glioma

Who this might be right for
High Grade Glioma
Diffusion Pharmaceuticals Inc 1
Testing effectiveness (Phase 2)Study completedNCT01248936
What this trial is testing

RO5185426 in Patients With Metastatic Melanoma

Who this might be right for
Malignant Melanoma
Hoffmann-La Roche 374
Post-approval studies (Phase 4)Study completedNCT07313111
What this trial is testing

Thymoquinone as an add-on Therapy for the Management of Patients With Diabetic Peripheral Neuropathy

Who this might be right for
Diabetic Peripheral Neuropathy (DPN)
Hawler Medical University 50
Testing effectiveness (Phase 2)Looking for participantsNCT06622434
What this trial is testing

New Adjuvant Vaccine in Glioblastoma, a Phase 1/2a Study

Who this might be right for
Newly Diagnosed Glioblastoma
Assistance Publique - Hôpitaux de Paris 35
Early research (Phase 1)UnknownNCT04357509
What this trial is testing

The Tolerance,Pharmacokinetic Characteristics,Safety and Efficacy of ScTIL210 in the Treatment of Melanoma

Who this might be right for
Melanoma
Peking University Cancer Hospital & Institute 32
Not applicableEnded earlyNCT04763031
What this trial is testing

Recurrent GBM With Maximal Neurosurgical Removal and Treatment With IORT

Who this might be right for
GlioblastomaGBMRecurrent GBM
Parkridge Medical Center 1
Not applicableStudy completedNCT00928031
What this trial is testing

Long-term Data Collection for Subjects in MDX-010 Studies

Who this might be right for
Metastatic Melanoma
Bristol-Myers Squibb 160
Testing effectiveness (Phase 2)Study completedNCT02662972
What this trial is testing

Botulinum Toxin Type A Block of the Sphenopalatine Ganglion in Trigeminal Neuralgia. Safety Issues.

Who this might be right for
Trigeminal NeuralgiaHeadache Disorders
Norwegian University of Science and Technology 10
Very early researchStudy completedNCT03647657
What this trial is testing

177Lu-PP-F11N in Combination With Sacubitril for Receptor Targeted Therapy and Imaging of Metastatic Thyroid Cancer

Who this might be right for
Thyroid Cancer, Medullary
University Hospital, Basel, Switzerland 8
Not applicableActive Not RecruitingNCT05678101
What this trial is testing

TENS for Relief of Postoperative Pain in Orthopedic Patients

Who this might be right for
Orthopedic DisorderPost Operative PainHip Fractures+2 more
Karolinska University Hospital 30
Not applicableStudy completedNCT03752619
What this trial is testing

Peripheral Nerve Stimulation(PNS) for Subacromial Impingement Syndrome(SIS)

Who this might be right for
Shoulder PainShoulder Impingement SyndromeShoulder Tendinitis+2 more
MetroHealth Medical Center 116
Large-scale testing (Phase 3)Study completedNCT00790400
What this trial is testing

Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)

Who this might be right for
Tuberous Sclerosis Complex (TSC)Lymphangioleiomyomatosis (LAM)
Novartis Pharmaceuticals 118
Testing effectiveness (Phase 2)Looking for participantsNCT06607692
What this trial is testing

Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).

Who this might be right for
Solid Tumor CancerMedulloblastomaHigh Risk Neuroblastoma+19 more
Fundación de investigación HM 25
Not applicableUnknownNCT02383134
What this trial is testing

Maximal Distance for Successful Supraclavicular Block

Who this might be right for
Regional AnesthesiaUltrasoundSupraclavicular Block
Tunisian Military Hospital 44
Not applicableStudy completedNCT00704457
What this trial is testing

Impact Of Sacral Neuromodulation On Urine Markers For Interstitial Cystitis (IC)

Who this might be right for
Interstitial Cystitis
Kenneth Peters, MD 11
Not applicableNot Yet RecruitingNCT06524219
What this trial is testing

Comparison of Nerve-sparing Techniques in Radical Prostatectomy for Oncological Outcome and Functional Recovery.

Who this might be right for
Prostate Cancer
The First Affiliated Hospital with Nanjing Medical University 150
Testing effectiveness (Phase 2)Looking for participantsNCT07537400
What this trial is testing

Patients Between the Ages of 12 Months to 21 Years With Newly-Diagnosed High-Risk Neuroblastoma Will Receive Children's Oncology Group (COG) Type Recommended Therapy With the Addition of Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) to Induction Cycles 1-5

Who this might be right for
High-Risk Neuroblastoma
Shaare Zedek Medical Center 10
Not applicableUnknownNCT06078475
What this trial is testing

Efficacy of Modified Perichondral Approach Thoracoabdominal Nerve Block For Post Cesarean Section

Who this might be right for
Cesarean Section
Bursa City Hospital 60
Not applicableStudy completedNCT05213819
What this trial is testing

Phonophoresis, Low-Level Laser Therapy and Exercise in the Treatment of Carpal Tunnel Syndrome

Who this might be right for
Carpal Tunnel Syndrome
Kutahya Health Sciences University 45
Testing effectiveness (Phase 2)Study completedNCT02537600
What this trial is testing

Vemurafenib and Cobimetinib Combination in BRAF Mutated Melanoma With Brain Metastasis

Who this might be right for
Malignant Melanoma
Center Eugene Marquis 43
Next Page